Validation of a Demography-Based Adaptive QTc Formula using Pediatric and Adult Datasets Acquired from Humans and...

Area of Science:

• Cardiology
• Biomedical Engineering
• Pharmacology

Background:

• Corrected QT (QTc) is a crucial ECG biomarker for cardiovascular disease risk stratification and drug safety.
• Existing QTc formulae show inconsistent performance across diverse demographics (age, sex, disease, species).

Purpose of the Study:

• To introduce and evaluate a novel adaptive QTc (QTcAd) formula that adjusts for demographic variability, specifically age.
• To compare the efficacy and accuracy of the QTcAd formula against widely used QTc correction methods.

Main Methods:

• The QTcAd formula was tested across diverse age groups in human and guinea pig electrocardiogram (ECG) data.
• Performance was assessed using linear regression (slope and R²) of the QT-HR relationship.
• Accuracy was further evaluated using epicardial electrical and optical voltage data from guinea pig hearts.

Main Results:

• QTcAd consistently outperformed other formulae in both human and guinea pig subjects across all age groups.
• QTcAd effectively nullified the inverse HR-QT relationship in a 20-year-old human group (R²=5.1E-09, slope=-3.5E-05).
• QTcAd demonstrated superior accuracy compared to the Bazett (QTcB) and Benatar (QTcBe) formulae, and approximated optical pseudo-QT intervals better than all other formulae.

Conclusions:

• The demography-based QTcAd formula exhibits superior performance in human and guinea pig age groups.
• QTcAd has the potential to enhance the efficacy of QTc for cardiovascular disease diagnosis, risk stratification, and drug safety testing.